From Mice to Men: Potential New Target Discovered for Treating Acute Myeloid Leukemia

Bone marrow failure due to acute myeloid leukemia (AML) is a significant factor behind the disease’s high rate of morbidity and mortality. Previous studies in mice suggest that AML cells inhibit healthy hematopoietic (blood) stem and progenitor cells (HSPC). A study released in STEM CELLS adds to this extent of knowledge by showing how secreted cell factors, [...]

Published May 20, 2021 at 08:09AM. Read full article at Stem Cells in the News Portal.